Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual TxA2 and PGD2 antagonists described by scientists at Shionogi

Jan. 23, 2002

Advair and Flovent Diskus recommended for approval by FDA committee

Jan. 23, 2002

T-bet: an attractive target for antiasthmatic and possibly other drugs

Jan. 23, 2002

New GSK compounds useful for treatment and prophylaxis of sCD23-mediated conditions

Jan. 22, 2002

Board recommends continuing phase III trial of Actimmune for IPF

Jan. 18, 2002

Recent patents cover Roche's new lactam muscarinic receptor antagonists

Jan. 17, 2002

Nikken Chemicals describes new series of TNF-alpha production inhibitors

Jan. 16, 2002

Corus licenses asthma technology from Mayo Clinic

Jan. 16, 2002

NVP-ABE-171: a PDE4 inhibitor with better activity than Ariflo in rodent models of lung inflammation

Jan. 15, 2002

Airways-selective potassium channel opener in development by Novartis for asthma Rx

Jan. 15, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...